ISRG vs SLB: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and SLB N.V. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
Intuitive Surgical, Inc. Β· Healthcare
$451.29
+130.4% upside to fair value
Grade B High Quality
VS
SLB N.V. Β· Energy
$51.92
-20.2% upside to fair value
Med Conviction Grade C+
QuantHub Verdict
ISRG has more upside to fair value (+130.4%). SLB trades at a lower forward P/E (18.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ISRG SLB
Current Price $451.29 $51.92
Fair Value Estimate $1,039.74 $41.43
Upside to Fair Value +130.4% -20.2%
Market Cap $160.3B $77.9B
Forward P/E 53.8x 18.6x
EV / EBITDA 40.5x 9.2x
Price / Sales 15.2x 2.2x
Price / FCF 64.3x 16.1x
Revenue Growth YoY +23.0% -1.6%
Gross Margin 66.3% 18.21%
Operating Margin 30.5% 15.28%
Return on Equity 17.0% 12.83%
Dividend Yield 0% 2.21%
FCF Yield 1.55% 6.21%
Analyst Consensus Strong Buy Buy
Investment Thesis
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
SLB β€” SLB N.V.
SLB is the world's largest oilfield services company with $35.7B in FY2025 revenue, operating across four divisions: Digital and Integration, Reservoir Performance, Well Construction, and Production Systems. The company completed the ChampionX acquisition in 2025 and is pursuing a digital transformation and AI-driven strategy. At $51.92, SLB trades at 2.18x P/S (in the fair range of the 5-year di…
Accumulation Zones
Metric ISRG SLB
Zone Low $779.81 $34.00
Zone High $883.78 $39.00
In Buy Zone? Yes No
← ISRG Research    SLB Research β†’    All Research